tiprankstipranks
Trending News
More News >

Invion Expands Share Issuance and Explores New Opportunities for Photosoft™ Technology

Story Highlights
Invion Expands Share Issuance and Explores New Opportunities for Photosoft™ Technology

The latest announcement is out from Invion ( (AU:IVX) ).

Invion Limited has issued over 7 million new shares at $0.14 each, under a Tranche 1 Placement, without disclosure to investors as per the Corporations Act. The company is in preliminary talks with RMW Cho Group Limited to potentially expand its rights to Photosoft™ technology into new territories or indications, although no binding agreement has been reached yet.

More about Invion

Invion is a life-science company focused on the global research and development of Photosoft™ technology for cancer treatment. The company holds licensing rights in Australia and New Zealand and is listed on the ASX. Research and clinical trials are supported by RMW Cho Group Limited, the licensor of the technology.

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $4.65M

See more data about IVX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App